200,000+ products from a single source!
sales@angenechem.com
CAS No: 131060-14-5 Catalog No: AG000VGJ MDL No:MFCD00898838
Title | Journal |
---|---|
Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. | Journal of cellular physiology 20110901 |
Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells. | Endocrinology 20081001 |
Synthesis and biological activity of a novel squalene epoxidase inhibitor, FR194738. | Bioorganic & medicinal chemistry letters 20040209 |
Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes. | Journal of lipid research 20030101 |
[Other antihyperlipidemic drugs with novel mechanism]. | Nihon rinsho. Japanese journal of clinical medicine 20010301 |
Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells: a new type of potent squalene epoxidase inhibitors. | Bioorganic & medicinal chemistry letters 19980602 |
(Aryloxy)methylsilane derivatives as new cholesterol biosynthesis inhibitors: synthesis and hypocholesterolemic activity of a new class of squalene epoxidase inhibitors. | Journal of medicinal chemistry 19950818 |
© 2019 Angene International Limited. All rights Reserved.